• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (61)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Alzheimer Disease  • Cerebrovascular Disease  • Dementias  • Neuroendocrinology  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Cardiovascular System  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

Elizabeth P. Helzner, PhD; José A. Luchsinger, MD; Nikolaos Scarmeas, MD; Stephanie Cosentino, PhD; Adam M. Brickman, PhD; M. Maria Glymour, PhD; Yaakov Stern, PhD

Arch Neurol. 2009;66(3):343-348.

Background  Vascular factors including medical history (heart disease, stroke, diabetes, and hypertension), smoking, and prediagnosis blood lipid measurements (cholesterol: total, high-density lipoprotein, low-density lipoprotein [LDL-C], and triglyceride concentrations) may be predictors for progression of Alzheimer disease (AD).

Objective  To determine whether prediagnosis vascular risk factors are associated with progression of AD.

Design  Inception cohort followed up longitudinally for a mean of 3.5 (up to 10.2) years.

Setting  Washington Heights/Inwood Columbia Aging Project, New York, New York.

Patients  One hundred fifty-six patients with incident AD (mean age at diagnosis, 83 years).

Main Outcome Measure  Change in a composite score of cognitive ability from diagnosis onward.

Results  In generalized estimating equation models (adjusted for age, race/ethnicity, and years of education), higher cholesterol (total cholesterol and LDL-C) concentrations and history of diabetes were associated with faster cognitive decline. Each 10-U increase in cholesterol and LDL-C was associated with a 0.10-SD decrease in cognitive score per year of follow-up (P < .001 for total cholesterol; P = .001 for LDL-C). High-density lipoprotein cholesterol and triglyceride concentrations were not associated with rate of decline. A history of diabetes was associated with an additional 0.05-SD decrease in cognitive score per year (P = .05). History of heart disease and stroke were associated with cognitive decline only in carriers of the apolipoprotein E 4 (APOE-4) gene. In a final generalized estimating equation model that included high-density lipoprotein cholesterol and LDL-C concentrations and history of diabetes, only higher LDL-C was independently associated with faster cognitive decline.

Conclusion  Higher prediagnosis total cholesterol and LDL-C concentrations and history of diabetes were associated with faster cognitive decline in patients with incident AD, which provides further evidence for the role of vascular risk factors in the course of AD.

Author Affiliations: Gertrude H. Sergievsky Center (Drs Helzner, Luchsinger, Scarmeas, Cosentino, and Stern), Taub Institute for Research in Alzheimer's Disease and the Aging Brain (Drs Luchsinger, Scarmeas, Brickman, and Stern), and Department of Neurology (Drs Luchsinger, Scarmeas, and Stern), Columbia University Medical Center; and Department of Epidemiology, Mailman School of Public Health, Columbia University (Dr Glymour), New York, New York.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(3):298-299.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebrovascular lesions induce transient {beta}-amyloid deposition
Garcia-Alloza et al.
Brain 2011;134:3697-3707.
ABSTRACT | FULL TEXT  

Cholesterol Level and Statin Use in Alzheimer Disease: I. Review of Epidemiological and Preclinical Studies
Shepardson et al.
Arch Neurol 2011;68:1239-1244.
ABSTRACT | FULL TEXT  

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis
Sutedja et al.
J. Neurol. Neurosurg. Psychiatry 2011;82:638-642.
ABSTRACT | FULL TEXT  

Latest advances on interventions that may prevent, delay or ameliorate dementia
Wilson et al.
Therapeutic Advances in Chronic Disease 2011;2:161-173.
ABSTRACT  

Cerebrovascular risk factors and preclinical memory decline in healthy APOE {varepsilon}4 homozygotes
Caselli et al.
Neurology 2011;76:1078-1084.
ABSTRACT | FULL TEXT  

Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease
Reitz et al.
Arch Neurol 2010;67:1491-1497.
ABSTRACT | FULL TEXT  

Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors
Ritchie et al.
BMJ 2010;341:c3885-c3885.
ABSTRACT | FULL TEXT  

Long-term Cognitive and Psychological Outcomes in the Awakening and Breathing Controlled Trial
Jackson et al.
Am. J. Respir. Crit. Care Med. 2010;182:183-191.
ABSTRACT | FULL TEXT  

DHA May Prevent Age-Related Dementia
Cole and Frautschy
J. Nutr. 2010;140:869-874.
ABSTRACT | FULL TEXT  

Advances in Vascular Cognitive Impairment
Gorelick and Bowler
Stroke 2010;41:e93-e98.
FULL TEXT  

Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker et al.
Arch Neurol 2010;67:71-79.
ABSTRACT | FULL TEXT  

Probucol Increases Glutathione Peroxidase-1 Activity and Displays Long-Lasting Protection against Methylmercury Toxicity in Cerebellar Granule Cells
Farina et al.
Toxicol Sci 2009;112:416-426.
ABSTRACT | FULL TEXT  

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease
Sanz et al.
Neurology 2009;73:1359-1366.
ABSTRACT | FULL TEXT